Scientific Officer (Thoracic Oncology Immunotherapy Group)

29/09/2019, 23:55

Cancer Therapeutics
Thor Onco Immuno Group
Full time
Fixed Term
Appointment will be on a Fixed Term Contract to 30/9/2022
circa £26,000
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The group of Dr Astero Klampatsa is looking for a highly motivated Scientific Officer to provide critical organisational and practical support to the team in their study of anti-tumour immune responses to immunotherapy and discover predictors of response to immune checkpoint blockade using clinical tumour samples. 

Candidates would need to have a first degree in a biological or physical science (PhD desirable), extensive experience in mammalian cell culture, immunology, cell biology and chemistry techniques, including flow cytometry. For full details please review the attached job description and person specification.

The appointment will be on a Fixed Term Contract to 30/9/2022 in the first instance.

Starting salary will be based on previous experience. 

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.
Additional Documentation for Candidates

This Program is closed to applications.